Pasi A Jänne

62PUBLICATIONS
674CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Sep 17, 2026
Germline EGFR T790M mutation and lung cancer risk.

|Jul 14, 2026
Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer Receiving First-line Osimertinib.

|Jul 06, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|May 13, 2026
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion.

|Apr 28, 2026
The SOS1 Inhibitor BI 1701963 as Monotherapy or in Combination with Trametinib in Patients with KRAS Mutation-Positive Solid Tumors.

Pageof 11

Frequent Collaborators

12 joint publications

Lynette M Sholl

8 joint publications

Prafulla Gokhale

8 joint publications

James Chih-Hsin Yang

8 joint publications

Melissa L Johnson